This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Atrial Fibrillation
+2

Warfarin Patient Self-management Implementation in the US Healthcare System

Sponsored by University of Utah

About this trial

Last updated a year ago

Study ID

IRB_00141141

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 2 months ago

What is this trial about?

In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.

What are the participation requirements?

Yes

Inclusion Criteria

- At least 18 years of age treated with warfarin for any indication for at least 9 months prior to enrollment

- Demonstrate the willingness and ability to test their own INR using a home INR monitoring device or have same-day access to clinic-derived INR results (e.g., via electronic medical record secure messaging)

- Willing to make independent decisions about warfarin dosing based on INR results

- Able to perform INR tests at least every 2 weeks

- Currently have and willing to maintain internet access for the duration of the study in order to complete online data collection forms

- Have an anticipated duration of warfarin therapy of at least 6 months

No

Exclusion Criteria

- Goal INR range other than 2.0-3.0 or 2.5-3.5

- Known poor adherence to warfarin therapy

- Non-English speaking

- Inability or refusal to provide written informed consent

Locations

Location

Status

Recruiting
Recruiting
Completed
Completed